160 related articles for article (PubMed ID: 38461463)
1. The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors.
Partelli S; Fermi F; Fusai GK; Tamburrino D; Lykoudis P; Beghdadi N; Dokmak S; Wiese D; Landoni L; Reich F; Busch ORC; Napoli N; Jang JY; Kwon W; Armstrong T; Allen PJ; He J; Javed A; Sauvanet A; Bartsch DK; Salvia R; van Dijkum EJMN; Besselink MG; Boggi U; Kim SW; Wolfgang CL; Falconi M
Ann Surg Oncol; 2024 Jun; 31(6):4096-4104. PubMed ID: 38461463
[TBL] [Abstract][Full Text] [Related]
2. ASO Visual Abstract: The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors.
Partelli S; Fermi F; Fusai GK; Tamburrino D; Lykoudis P; Beghdadi N; Dokmak S; Wiese D; Landoni L; Reich F; Busch ORC; Napoli N; Jang JY; Kwon W; Armstrong T; Allen PJ; He J; Javed A; Sauvanet A; Bartsch DK; Salvia R; van Dijkum EJMN; Besselink MG; Boggi U; Kim SW; Wolfgang CL; Falconi M
Ann Surg Oncol; 2024 Jun; 31(6):4123-4124. PubMed ID: 38519785
[No Abstract] [Full Text] [Related]
3. Implications of incidentally discovered, nonfunctioning pancreatic endocrine tumors: short-term and long-term patient outcomes.
Haynes AB; Deshpande V; Ingkakul T; Vagefi PA; Szymonifka J; Thayer SP; Ferrone CR; Wargo JA; Warshaw AL; Fernández-del Castillo C
Arch Surg; 2011 May; 146(5):534-8. PubMed ID: 21576607
[TBL] [Abstract][Full Text] [Related]
4. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
[TBL] [Abstract][Full Text] [Related]
5. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Role of Examined and Positive Lymph Nodes after Distal Pancreatectomy for Non-Functioning Neuroendocrine Neoplasms.
Guarneri G; de Mestier L; Landoni L; Partelli S; Gaujoux S; Andreasi V; Nessi C; Dokmak S; Fontana M; Dousset B; Ruszniewski P; Bassi C; Falconi M; Sauvanet A
Neuroendocrinology; 2021; 111(8):728-738. PubMed ID: 32585667
[TBL] [Abstract][Full Text] [Related]
7. Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.
Gharios J; Hain E; Dohan A; Prat F; Terris B; Bertherat J; Coriat R; Dousset B; Gaujoux S
Best Pract Res Clin Endocrinol Metab; 2019 Oct; 33(5):101294. PubMed ID: 31351817
[TBL] [Abstract][Full Text] [Related]
8. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
[TBL] [Abstract][Full Text] [Related]
9. Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?
Fernández-Cruz L; Blanco L; Cosa R; Rendón H
World J Surg; 2008 May; 32(5):904-17. PubMed ID: 18264824
[TBL] [Abstract][Full Text] [Related]
10. Computed Tomography Features Predictive of Lymph Node Involvement in Patients With a Nonfunctioning Pancreatic Neuroendocrine Tumor.
Choi SH; Kim HJ; Kim SY; Byun JH; Kim KW; Song KB; Kim SC; Kim MH
Pancreas; 2017 Sep; 46(8):1056-1063. PubMed ID: 28787330
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting.
Partelli S; Andreasi V; Rancoita PMV; Perez-Sanchez E; Muffatti F; Balzano G; Crippa S; Di Serio C; Falconi M
Surg Endosc; 2021 Jan; 35(1):165-173. PubMed ID: 31953734
[TBL] [Abstract][Full Text] [Related]
12. Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database.
Assi HA; Mukherjee S; Kunz PL; Machiorlatti M; Vesely S; Pareek V; Hatoum H
Oncologist; 2020 Feb; 25(2):e276-e283. PubMed ID: 32043766
[TBL] [Abstract][Full Text] [Related]
13. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
[TBL] [Abstract][Full Text] [Related]
15. Prognosis after surgery for multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: Functionality matters.
van Beek DJ; Nell S; Verkooijen HM; Borel Rinkes IHM; Valk GD; ; Vriens MR; ;
Surgery; 2021 Apr; 169(4):963-973. PubMed ID: 33220975
[TBL] [Abstract][Full Text] [Related]
16. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticoduodenectomy combined with vascular resection and reconstruction for patients with locally advanced pancreatic cancer: a multicenter, retrospective analysis.
Gong Y; Zhang L; He T; Ding J; Zhang H; Chen G; Zhang D; Wu Z; Chen Q; Fan H; Wang Q; Bie P; Wang H
PLoS One; 2013; 8(8):e70340. PubMed ID: 23936411
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors: Surgical outcomes and survival analysis.
Fahmy JN; Varsanik MA; Hubbs D; Eguia E; Abood G; Knab LM
Am J Surg; 2021 Mar; 221(3):529-533. PubMed ID: 33375953
[TBL] [Abstract][Full Text] [Related]
19. Incidence and impact of Textbook Outcome among patients undergoing resection of pancreatic neuroendocrine tumors: Results of the US Neuroendocrine Tumor Study Group.
Heidsma CM; Hyer M; Tsilimigras DI; Rocha F; Abbott DE; Fields R; Smith PM; Poultsides GA; Cho C; Maithel SK; Pawlik TM;
J Surg Oncol; 2020 Jun; 121(8):1201-1208. PubMed ID: 32185804
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Guided Robotic Enucleation of Pancreatic Neuroendocrine Tumors.
Di Benedetto F; Magistri P; Ballarin R; Tarantino G; Bartolini I; Bencini L; Moraldi L; Annecchiarico M; Guerra F; Coratti A
Surg Innov; 2019 Feb; 26(1):37-45. PubMed ID: 30066609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
